PolyProx Therapeutics is a biotechnology company focused on the discovery and development of a new class of drugs, Polyproxin® molecules, to treat cancer and neurodegenerative diseases. Polyproxin® molecules are biopharmaceuticals that selectively target disease-causing proteins and use natural cellular pathways to degrade or remove these proteins.